2 hours Rhythm Pharmaceuticals, Inc. to Post Q3 2024 Earnings of ($0.77) Per Share, HC Wainwright Forecasts (NASDAQ:RYTM) MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) – Research analysts at HC Wainwright cut their Q3 2024 EPS estimates for shares of Rhythm Pharmaceuticals in a note issued to investors on Monday, October 7th. HC Wainwright analyst R. Selvara…
Earnings · Nasdaq 100 · Pharmaceuticals · Science